Chemicals Industry Today

Pharma Grade Sodium Bicarbonate Market Growing at 4.1% CAGR, Expected to Reach USD0.98 billion by 2033- Strategic Revenue Insights

The Pharma Grade Sodium Bicarbonate Market is growing steadily, driven by rising demand from pharmaceutical manufacturers for high-purity sodium bicarbonate used in APIs, antacids, dialysis, and excipients. Growth is supported by increasing chronic disease prevalence (e.g. kidney disorders), expanding dialysis needs, and stricter purity standards in drug formulation globally.
Published 03 December 2025

London, UK – Dec 2025 | Strategic Revenue Insights Inc. – The global Pharma Grade Sodium Bicarbonate market is projected to grow from US$0.68 billion in 2024 to US$0.98 billion by 2033, based on our latest analysis.

The increase reflects a compound annual growth rate (CAGR) of 4.1% over the forecast period, signalling steady expansion in demand for high-purity sodium bicarbonate used in pharmaceutical applications.

A comprehensive assessment of this rapidly evolving market can be accessed through Strategic Revenue Insights at the link below, focused on Pharma Grade Sodium Bicarbonate:

https://www.strategicrevenueinsights.com/industry/pharma-grade-sodium-bicarbonate-market

Sodium bicarbonate’s role as a critical ingredient in antacid formulations, hemodialysis solutions, tablet coatings and effervescent tablets anchors much of the demand. As global rates of chronic diseases especially renal and gastrointestinal disorders rise alongside expanding healthcare infrastructure, the need for pharma-grade sodium bicarbonate continues to climb.

Major players such as Solvay SA, Tata Chemicals Limited, Church & Dwight Co., Inc. and Novacarb dominate the competitive landscape, leveraging their manufacturing expertise and compliance capabilities to supply high-purity bicarbonate globally.

Applications remain broad: antacids continue to absorb a substantial share, while hemodialysis, tablet coating and effervescent tablet production represent other core segments. Pharmaceutical companies, hospitals and research laboratories stand out as primary end-users of pharma-grade sodium bicarbonate.

Browse the associated report:

https://www.strategicrevenueinsights.com/ja/industry/pharma-grade-sodium-bicarbonate-market

https://www.strategicrevenueinsights.com/kr/industry/pharma-grade-sodium-bicarbonate-market

https://www.strategicrevenueinsights.com/pt/industry/pharma-grade-sodium-bicarbonate-market

https://www.strategicrevenueinsights.com/it/industry/pharma-grade-sodium-bicarbonate-market

https://www.strategicrevenueinsights.com/es/industry/pharma-grade-sodium-bicarbonate-market

https://www.strategicrevenueinsights.com/da/industry/pharma-grade-sodium-bicarbonate-market

https://www.strategicrevenueinsights.com/de/industry/pharma-grade-sodium-bicarbonate-market

https://www.strategicrevenueinsights.com/fr/industry/pharma-grade-sodium-bicarbonate-market

Regionally, while North America and Europe maintain strong market shares owing to advanced pharmaceutical industries and strict quality standards, emerging economies particularly in Asia Pacific and Latin America  are poised for significant growth, buoyed by rising healthcare investment, increasing disease burden and expanding drug-manufacturing capacity.

Technological impact factors such as advancements in drug delivery systems and the development of new therapeutic applications for sodium bicarbonate are likely to influence the market. Client demand transformations are expected to continue, with a focus on high-quality, sustainable, and innovative pharmaceutical solutions. Overall, the market is poised for steady growth, driven by the increasing demand for pharma-grade sodium bicarbonate and the expanding pharmaceutical industry.

Looking ahead to 2033, the Pharma Grade Sodium Bicarbonate market is likely to benefit from growing demand for high-purity excipients, expanding dialysis-related healthcare, and increasing demand for antacid and other bicarbonate-based formulations. Regulatory pressure for pharmacopeia-compliant ingredients and ongoing R&D into novel therapeutic uses may further broaden the application base.

Related Reports:

https://www.strategicrevenueinsights.com/industry/solvent-free-epoxy-primer-market

https://www.strategicrevenueinsights.com/industry/jlox-molecular-sieve-market

https://www.strategicrevenueinsights.com/industry/refractory-grade-bauxite-raw-materials-market

https://www.strategicrevenueinsights.com/industry/tundish-powder-market

https://www.strategicrevenueinsights.com/industry/tundish-covering-compound-market

About Strategic Revenue Insights Inc.

Strategic Revenue Insights Inc., a subsidiary of SRI Consulting Group Ltd, empowers organizations worldwide with data driven market intelligence. Headquartered in London, United Kingdom, the firm delivers syndicated research reports, tailored consulting solutions, and actionable insights that equip clients to make confident, future focused strategic decisions. Its team of seasoned analysts continuously tracks markets, identifies emerging trends, and uncovers growth opportunities to support long-term client success. As part of SRI Consulting Group Ltd, Strategic Revenue Insights Inc. is committed to accuracy, clarity, and practical relevance, helping businesses optimize strategies and accelerate revenue growth.

Media Contact

Company Name: Strategic Revenue Insights Inc.

Contact Person: Ashwani

Email: sales@strategicrevenueinsights.com

Phone: +44 7877 403352

Address: Suite 10, Capital House, 61 Amhurst Road, E8 1LL

City: London

Country: United Kingdom

Website: www.strategicrevenueinsights.com

Website: www.strategicpackaginginsights.com


Other Industry News

Ready to start publishing

Sign Up today!